About: Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1997 (uk) article scientifique publié en 1997 (fr) im November 1997 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1997 (en) artículu científicu espublizáu en payares de 1997 (ast)
publication date	wds:Q73867171-DE5B1FD0-ADAE-4FAE-A8C5-C00F6CD9E867
publication date	1997-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73867171-1D3952E6-1FE7-4090-8434-8BB8F1D5AEC6 wds:Q73867171-2E8EF009-DD10-479D-8E01-9289D7544353 wds:Q73867171-3D2CAC68-FD6D-4E78-ADA8-E38365E05967 wds:Q73867171-468FDF35-0B6B-4C13-8A01-BBC1DD6F2F5A wds:Q73867171-6904291D-C6CF-429E-BBE4-85A5CFD2224E wds:Q73867171-70C46DD1-8BF1-4066-AEB4-42B37F603FCF wds:Q73867171-7F706629-3EC3-4B6A-868A-F4AACC819ADC wds:Q73867171-8076EA05-086D-4A2D-B4DC-3522052663B0 wds:Q73867171-8A9BB490-2D80-494E-84E2-DD8F891CFDC7 wds:Q73867171-B08225DE-637F-4321-B97A-26FE61C1FB3C wds:Q73867171-B8F2ECE6-C346-42AF-9D4E-D68EFD66CE0A
author name string	A M Reed S L Bowyer B M Feldman C A Wallace M H Passo I M Katona C B Lindsley M D Perez L S Zemel R M Rennebohm S H Ballinger
rdfs:label	Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (en) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (nl)
skos:prefLabel	Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (en) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (nl)
name	Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (en) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (nl)
author	wds:Q73867171-1d202248-496e-39b6-5988-4fd2df120faa wds:Q73867171-9126D5F6-56A2-4038-BBF8-FBBE82CFA363 wds:Q73867171-FA7A2E3D-9AA9-4553-8F99-D4DAE864591A
author	Peter A. Lachenbruch Frederick W. Miller Lisa G. Rider
title	wds:Q73867171-569E0D06-9ADF-411D-9D0A-87F0492FCB98
title	Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group (en)
page(s)	wds:Q73867171-D9A26873-9FB2-4FA2-BB91-C1E6BEFA7B20
page(s)	1976-1983
instance of	wds:Q73867171-F2111319-E102-4840-B3AA-CA61E1D9EC11
instance of	scholarly article
main subject	wds:Q73867171-A4603870-4D17-4595-8010-7027C2ADA5C0
main subject	dermatomyositis
PubMed ID	wds:Q73867171-91754841-2C9C-42E8-AFF4-42CBBAA22D23
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9365086
PubMed ID	9365086
published in	wds:Q73867171-2E16A1F9-8C29-46A8-9FA4-002906821E62
published in	Arthritis and Rheumatism
issue	wds:Q73867171-C0209931-C1CC-41B2-B4FB-C9325993967A
volume	wds:Q73867171-DE1625C7-D5A1-4A19-B7C5-79F0B0E02AB3
issue	11
volume	40
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73867171
is cites work of	The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy. Disease activity measures in paediatric rheumatic diseases Responsiveness to exercise training in juvenile dermatomyositis: a twin case study Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C- Inflammatory muscle disease: clinical presentation and assessment of patients Physical function assessment tools in pediatric rheumatology Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis Outcome measures in childhood rheumatic diseases. Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Development of outcome measures for autoimmune dermatoses Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation Efficacy of ultrasound elastography in detecting active myositis in children: can it replace MRI? Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment Update on the assessment of children with juvenile idiopathic inflammatory myopathy The assessment and importance of disease activity versus disease damage in patients with inflammatory myopathy A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy Endothelial and inflammatory biomarker profile at diagnosis reflects clinical heterogeneity of juvenile dermatomyositis and is prognostic for response to treatment in two independent cohorts Oral cyclophosphamide in treatment of patients with refractory idiopathic inflammatory myopathies: a retrospective observational study The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study
is cites work of	wds:Q38148751-B5212B11-F211-4B05-AFA4-977654351D0D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software